The movement protein (MP) of Tobacco mosaic virus (TMV) facilitates the cell-to-cell transport of the viral RNA genome through plasmodesmata (Pd). A previous report described the functional reversion of a dysfunctional mutation in MP (Pro81Ser) by two additional amino acid substitution mutations (Thr104Ile and Arg167Lys). To further explore the mechanism underlying this intramolecular complementation event, the mutations were introduced into a virus derivative expressing the MP as a fusion to green fluorescent protein (GFP). Microscopic analysis of infected protoplasts and of infection sites in leaves of MP-transgenic Nicotiana benthamiana indicates that MP P81S -GFP and MP P81S;T104I;R167K -GFP differ in subcellular distribution. MP P81S -GFP lacks specific sites of accumulation in protoplasts and, in epidermal cells, exclusively localizes to Pd. MP P81S;T104I;R167K -GFP, in contrast, in addition localizes to inclusion bodies and microtubules and thus exhibits a subcellular localization pattern that is similar, if not identical, to the pattern reported for wild-type MP-GFP. Since accumulation of MP to inclusion bodies is not required for function, these observations confirm a role for microtubules in TMV RNA cell-to-cell transport.Plant virus movement is an active process that depends on viral-encoded movement proteins (MP) to facilitate intercellular transport of the viral genomes through plasmodesmata (Pd), channels in the cell wall that provide symplastic connections between adjacent cells. Numerous MPs have been reported to increase the permeability of Pd and to be able by themselves to move between cells. However, an increasing number of reports indicate that gating of Pd is insufficient to allow infection to spread into adjacent cells (8,10,49) and thus imply that infection depends on additional MP-mediated mechanisms. One of the most studied MPs is that of Tobacco mosaic virus (TMV) (4,15,21). The MP of TMV accumulates in Pd (2,22,45,60) and increases their size exclusion limit (48,66). In addition, MP binds both RNA and single-stranded DNA in vitro (16,17), suggesting that the MP may chaperone viral RNA in vivo. The formation of viral ribonucleoprotein complexes (vRNPs) is supported by the ability of microinjected MPs to mediate the transport of coinjected nucleic acids (23,28,46,62). The existence of vRNPs is also supported by biochemical studies (25,26,34) as well as by elegant microinjection experiments indicating that MP functions in vivo as a cis-acting mediator of plasmodesmal transport, requiring its physical association with the transported molecule (63).To further elucidate the cellular mechanism by which MP facilitates the spread of viral RNA (vRNA) or the proposed vRNP from virus-replicating cells into adjacent cells, several research groups have undertaken the characterization of host components that interact with TMV MP and have shown that a fusion between MP and green fluorescent protein (GFP) accumulates in Pd (31, 48) and also colocalizes with components of the cytoskeleton (30, 44) and ...